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13.11.001Abstract The thymine DNA glycosylase (TDG) is a multifunctional enzyme, which is essential for
embryonic development. It mediates the base excision repair (BER) of G:T and G:U DNA mis-
matches arising from the deamination of 5-methyl cytosine (5-MeC) and cytosine, respectively.
Recent studies have pointed at a role of TDG during the active demethylation of 5-MeC within
CpG islands. TDG interacts with the histone acetylase CREB-binding protein (CBP) to activate
CBP-dependent transcription. In addition, TDG also interacts with the retinoic acid receptor a
(RARa), resulting in the activation of RARa target genes. Here we provide evidence for the exis-
tence of a functional ternary complex containing TDG, CBP and activated RARa. Using global
transcriptome proﬁling, we uncover a coupling of de novo methylation-sensitive and RA-dependent
transcription, which coincides with a signiﬁcant subset of CBP target genes. The introduction of a
point mutation in TDG, which neither affects overall protein structure nor BER activity, leads to a
signiﬁcant loss in ternary complex stability, resulting in the deregulation of RA targets involved innecke AG).
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Le´ger H et al / TDG:CBP:RAR in Transcription and Epigenomics 9cellular networks associated with DNA replication, recombination and repair. We thus demonstrate
for the ﬁrst time a direct coupling of TDG’s epigenomic and transcription regulatory function
through ternary complexes with CBP and RARa.Introduction
The base excision repair (BER) enzyme thymine DNA glycosy-
lase (TDG) plays an important role in the maintenance of ge-
netic stability by correcting guanine:thymine (G:T) and
guanine:uracil (G:U) DNA mismatches [1,2]. These mispaired
basepairs arise from the spontaneous or catalyzed deamination
of 5-methyl cytosine (5-MeC) at CpG sites and cytosine,
respectively and would, if uncorrected, lead to G:C to A:T
transitions [3,4]. Depending on their location within the gen-
ome, such mutations can result in the loss of CpG dinucleo-
tides with potential impact on gene regulation or in codon
changes within coding regions, both of which can have serious
consequences such as cancer formation [5,6].
Apart from its function during BER, TDG interacts with
the retinoic acid receptor a (RARa) and the retinoid X recep-
tor (RXR) in a ligand-independent manner to enhance recep-
tor afﬁnity for their DNA target sites [7]. RAR and RXR
belong to a family of ligand-activated nuclear transcription
factors, which form homo- or heterodimers in order to activate
gene expression via binding to RA response elements (RAREs)
in target promoters [8]. In the absence of ligand, the RXR/
RARa heterodimer represses transcription by recruiting core-
pressors such as NCOR1, SMRT (NCOR2) and histone
deacetylases [9,10], whereas ligand binding mediates a confor-
mational change, allowing the recruitment of coactivators such
as histone acetyltransferases (HATs) and the basic transcrip-
tion machinery [11,12]. RARa can be activated by all-trans
RA (atRA) and 9-cis RA (9cRA), while RXR activation is
restricted to 9cRA only.
Moreover, TDG interacts with the HATs CREB-binding
protein (CBP) and p300, thereby enhancing their gene expres-
sion-activating capacities [13]. CBP and p300 are highly related
coactivators for a variety of transcription factors, including
CREB, the AP-1 proteins Jun and Fos, nuclear receptors
and the tumor suppressor p53 [14]. Via their HAT activity,
CBP/p300 are involved in chromatin remodeling at target pro-
moters in order to activate gene expression [15,16]. As reported
for TDG, CBP has also been shown to interact with RAR,
leading to the increased expression of RARE-driven reporters;
but unlike TDG, the binding of CBP is limited to ligand-acti-
vated RAR [17]. In line with these ﬁndings, a CBP knockdown
results in decreased expression of RARE-driven reporters [18].
Recent studies are pointing at an involvement of the BER
pathway in DNA demethylation [19]. In this context, TDG
may play a dual role in active demethylation as well as in
the inhibition of de novo DNA methylation, since it has been
shown to inhibit the activity of the DNA methyltransferases
Dnmt3a and Dnmt3b [20,21]. The homozygous knockout of
TDG leads to strong developmental defects and prenatal death
in mice [22,23]. Notably, some of the speciﬁc lethal phenotypes
of TDG null mice are comparable to those previously de-
scribed for CBP-knockout mouse embryos and for defects in
RA signaling [24,25]. The promoters of down-regulated genes
in TDG-deﬁcient mouse embryonic ﬁbroblasts (MEFs) show a
decreased CBP-binding [22] and elevated levels of CpGmethylation, supporting a role of TDG in DNA demethylation
[22,23].
Here, we investigate the interplay of RA-dependent and
DNA methylation-sensitive transcription with CBP target
genes in HEK293 cells. We provide evidence for a functional
ternary complex composed of TDG, CBP and activated
RARa, which consistently controls the expression of RA-
dependent target genes that are involved in important cellular
processes such as DNA replication, cell survival or cell cycle
regulation.Results and discussion
RA-dependent transcription coincides with de novo
methylation-sensitive gene expression
Given that TDG inﬂuences RARa- and CBP-dependent gene
expression and in view of a direct involvement of TDG in
the active demethylation of 5-MeC within CpG contexts, we
investigated whether there is coherence in gene expression
regulation between these different pathways, which would
point at TDG as a connector of epigenetic DNA modiﬁcation,
RA and CBP gene regulatory functions.
We compared gene expression proﬁles of HEK293 cells
overexpressing CBP with those of RA and 5-aza-20-deoxycyti-
dine (5-aza-dC)-treated cells (Figure 1). Incorporation of 5-
aza-dC has been shown to efﬁciently decrease de novo DNA
methylation by an irreversible inhibition of Dnmt activity
[26]. As expected by the transcription activating roles of
CBP, RA and DNA demethylation, all three conditions re-
sulted in gene activation in the majority of cases (Figure 1A).
Thereby, overexpression of CBP results in the statistically sig-
niﬁcant up-regulation of 1344 genes and down-regulation of
534 genes (P< 0.01) (Figure 1A, left panel). RA treatment
leads to the up-regulation of 418 genes and down-regulation
of 20 genes (Figure 1A, middle panel) and the inhibition of
de novo methylation by 5-aza-dC treatment affects the expres-
sion of 174 genes, of which expression of 145 and 29 genes is
up-regulated and down-regulated, respectively (Figure 1A,
right panel). When comparing the regulated gene sets of all
three conditions, we observe statistically signiﬁcant common
subsets of 256 (RA- vs. CBP-regulated genes), 102 (5-aza-dC-
vs. CBP-regulated genes) and 94 (RA- vs. 5-aza-dC-regulated)
genes, as indicated by the corresponding hypergeometric distri-
bution P values (Figure 1B). Moreover, there are 86 genes of
each common subset, which are statistically signiﬁcantly regu-
lated in all three conditions (Figure 1B, red). Comparing the
log2 fold changes in gene expression upon RA treatment with
those upon 5-aza-dC treatment reveals a highly signiﬁcant
(P< 0.001) positive correlation (R = 0.76, red), which is even
retained when comparing those genes signiﬁcantly regulated in
only one of the two conditions (R = 0.72, 5-aza-dC, brown;
R = 0.57, RA, green; Figure 1C, left panel). In similar com-
parisons, the CBP target genes split up into two groups. While
the common subsets with both 5-aza-dC target genes
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Figure 1 Comparison of CBP, 5-aza-dC and RA target genes by transcriptome proﬁling
A. Heatmaps of a substraction proﬁle of signiﬁcantly (post hoc pFDR P< 0.01) regulated genes after CBP overexpression (left), RA
treatment (middle) and 5-aza-dC treatment (right) of HEK293 cells. Mock transfected, ethanol- or DMSO-treated cells were used as
controls, respectively. The number of genes (L, column 1) that are positively (red shading) and negatively (blue shading) regulated is
shown together with the average over three independent biological replicate signals for each condition (S, column 2) and control
(S, column 3). The ﬁnal column (column 4) represents the post hoc P values (P). B. Venn diagram for the overlap of genes regulated in a
statistically signiﬁcant manner in all three conditions studied in A. The P values (hypergeometric distribution) for chance occurrence of
each overlap are indicated. Note that the overall overlap of 86 genes is almost entirely composed of genes which are derepressed by
5-aza-dC treatment and concomittantly activated by atRA treatment and CBP overexpression. C. Scatter plots of the overlaps of
methylation and RA-regulated genes (left), methylation and CBP-regulated genes (middle), and RA- and CBP- regulated genes (right)
reveals clear Pearson’s correlations (R). Genes with expression signiﬁcantly affected under both conditions compared in each panel are
indicated in red. Genes with expression signiﬁcantly affected upon CBP overexpression only (blue), by RA treatment only (green) and by
5-aza-dC treatment only (brown) are also indicated in different colors. ***P< 0.001. D. Scatter-plot of the common subset from panel B
in each condition (Y axis) compared to the overexpression of human TDG in HEK293 cells (X axis). E. Gene expression changes
of an assigned set of the common subset from panel B in HEK293 cells overexpressing human TDG and in TDG knockout mouse
embryonic ﬁbroblasts [23]. TDG, thymine DNA glycosylase; RA, retinoic acid; 5-aza-dC, 5-azacytidine; FLT1, ﬂs-related tyrosine
kinase 1; CDKN2B, cyclin-dependent kinase inhibitor 2B; RAMP1, receptor activity modifying protein 1; CAMK2D, calcium/
calmodulin-dependent protein kinase II delta; SH3BP5, SH3-domain binding protein 5; CTH, cystathionase.
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(R = 0.80; Figure 1C, right panel) show statistically signiﬁcant
(P< 0.001) positive correlations with CBP targets, genes with
expression only signiﬁcantly regulated by CBP do not show
any responsiveness to de novo methylation inhibition and RA
treatment. Notably, the whole sets of 5-aza-dC targets and
RA targets retained responsiveness to CBP, as indicated by
the corresponding Pearson correlation coefﬁcients of 0.66
(middle panel) and 0.78 (right panel), respectively (Figure 1C).
We validated our ﬁndings in human HEK293 cells using COS-
7 cells from the African green monkey and revealed the same
strong positive correlation between CBP, RA and 5-aza-dC
target genes in a different species (Figure S1). Taken together,
these results support a direct linkage between CBP-mediated
gene activation and CpG demethylation at promoter sites of
RA target genes. The classical RA pathway includes ligand-
mediated activation of homo- or heterodimers of RAR and
RXR bound to RAREs in the promoter region of target genes,
which subsequently affects gene expression directly or via the
recruitment of other transcription factors [27]. Our ﬁndings
suggest that gene activation by RA may include active or pas-
sive DNA demethylation of CpG and potentially also of non-
CpG sites in gene promoters. Indeed, several recent studies
have linked RA treatment with a global loss of CpG methyla-
tion in HL-60 and U937 cell lines [28]. RA has been shown to
up-regulate the expression of the tumor suppressors p16 and
p21 as well as E-cadherin expression by inducing promoter
hypomethylation [29,30]. In the case of p16 and p21, a RA-in-
duced decrease of Dnmt expression was held responsible for
promoter hypomethylation [29].
Since TDG has been shown to interact with CBP [13] and
RARa [7] in a functional manner and has been associated with
the active demethylation of CpG sites in gene promoters
[20,21], we further investigated whether there is a TDG-depen-
dent functional connection of these three pathways. By using
transcriptome proﬁling, we assessed the gene expression
changes of the common subset of CBP, RA and 5-aza-dC tar-
gets upon overexpression of human TDG in HEK293 cells.
Our results unveiled that expression of all genes are concomi-
tantly up-regulated by TDG, as judged by the highly statisti-
cally signiﬁcant Pearson correlation coefﬁcients (0.67 for
RA, 0.73 for 5-aza-dC and 0.89 for CBP) (Figure 1D). Indeed,
the expression of a randomly picked, assigned set of these
genes is down-regulated in mice upon knockout of murine
TDG, as assessed by gene expression proﬁling of previously
published data from TDG knockout MEFs [23], excluding
the possibility that artifacts induced by the overexpression of
TDG are responsible for the TDG responsiveness of these
genes (Figure 1E).A point mutation in TDG affects CBP-binding and ternary
complex stability
The catalytic domain of TDG, which is responsible for BER
activity, is important for RARa binding (Figure 2A) [7]. The
CBP binding interface of TDG is split into two distinct re-
gions, one located in the N-terminus and including the regula-
tory domain, which is known to be essential for G:T but not
G:U DNA repair activity [31], and the other located C-termi-
nally (Figure 2A) [13]. The former domain is important for
interacting with the HAT domain as well as the CH3 domainof CBP, while the latter one is restricted to CH3 interaction
only. Furthermore, the TDG regulatory domain contains four
lysine (K) residues, which are acetylated by CBP and thus rep-
resent sites of very tight TDG/CBP interaction [13]. Hence, ly-
sine residues are not only crucial for CBP recruitment and
activity, but are also hotspots for DNA binding by establishing
electrostatic interactions [32]. Notably, there is an enrichment
of proline (P) residues in the regulatory domain of TDG of
which several are located between two sites for CBP acetyla-
tion (Figure 2A, K59 on one hand and K83/K84/K87 on the
other hand). Proline residues are known to increase the rigidity
of polypeptide chains, making these residues possibly respon-
sible for the previously observed lack of ﬂexibility of the regu-
latory domain, as compared to the extreme N-terminus of
TDG [32]. Given the importance of the regulatory domain
for the interaction with CBP, we hypothesize that a proline
mutation in this region has the potential to modify the struc-
tural dynamics in this region, which might lead to an altered
CBP afﬁnity.
We thus generated a mutant form of TDG, TDG P65A, by
introducing a proline to alanine mutation using directed
mutagenesis at amino acid residue 65, which is located between
the aforementioned acetylation sites. We performed NMR
studies in order to assess the structure of TDG P65A and com-
pared it to that of wild-type TDG (Figure 2B). Importantly the
1H–15N HSQC spectrum of the mutated N-terminal domain of
TDG (amino acid residues 1–111, Figure 2B, left panel, red)
differs from that of the wild-type TDG N-terminal counterpart
(Figure 2B, left panel, black) solely by the resonances of the
amino acids directly ﬂanking the site of mutation, unveiling
no global structural consequences of the mutation on the
TDG N-terminus. Similarly, in the context of the full length
protein, P65A did not result in signiﬁcant structural changes
(Figure 2B, right panel).
The site of mutation, aside from serving as the interface
with CBP, is located in the region responsible for G:T but
not for G:U activity. We therefore performed glycosylase
activity assays with G:T and G:U mismatch-containing
DNA substrates to examine whether glycosylase activity would
be altered as a consequence of the mutation. Our results indi-
cated that compared to wild-type TDG (black curve), neither
G:T (left panel) nor G:U (right panel) repair kinetics were
signiﬁcantly altered when using TDG P65A (red curve)
(Figure 2C).
In order to analyze the capability of TDG P65A to interact
with CBP, we performed microscale thermophoresis (MST)
experiments with YFP-tagged CBP and HA-fused versions of
TDG P65A or wild-type TDG (Figure 3A). The MST tech-
nique relies on the fact that molecules move in a temperature
gradient from hot to cold (thermophoresis) [33,34]. Such
movement is impacted by complex formation, since complexes
exhibit an altered Brownian velocity when compared to their
compounds in a free state. MST techniques allow to follow
the thermophoresis of a ﬂuorescently labeled molecule (here
YFP-CBP) as a function of increasing concentrations of a
binding partner (here HA-TDG or HA-TDG P65A). While
these analyses with wild-type HA-TDG show saturating bind-
ing kinetics (Figure 3A, black curve, and Figure S2), HA-TDG
P65A afﬁnity for YFP-CBP is signiﬁcantly decreased by a
factor >3 (Figure 3A, red curve).
To investigate the effects of TDG P65A on the
RA-mediated transactivation of RARa-dependent genes, we
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Figure 2 Structure and activity of wild type TDG and the mutant P65A
A. Schematic structure of hTDG. The regions required for G:T and G:U mismatch recognition and processing (light and dark green,
respectively), the N- and C-termini, the regulatory domain (RD), the catalytic (CAT) domain as well as the interfaces with CBP (blue) and
RARa (brown) are indicated. The amino acid sequence of the RD is provided and the lysines that can be acetylated by CBP and the
proline 65 that was mutated in this study are highlighted in green and red, respectively. B. 1H–15N HSQC spectra of the N-terminus
(amino acid residues 1–111) (left panel) and full length hTDG (right panel). Spectra for wild-type and the P65A mutant are shown in black
and red, respectively. The resonances of the neighboring amino acids of P65 as well as the resonance of the introduced alanine are
indicated. C. Glycosylase kinetics of human TDG wild-type and P65A mutant on G:T and G:U repair. DNA nicking assays were
performed on a 25-mer dsDNA containing either a central G:T (left panel) or a G:U (right panel) mismatch. A 25-mer dsRNA containing
a central canonical G:C pair was used as a control.
12 Genomics Proteomics Bioinformatics 12 (2014) 8–18performed RA-dependent luciferase reporter assays using a
GAL4 DNA binding domain (DBD) fusion of RARa and a
GAL reporter gene in cells overexpressing wild-type TDG or
TDG P65A (Figure 3B). In the absence of TDG overexpres-
sion, RA treatment results in an approximate 75-fold increase
of reporter expression, which is statistically signiﬁcantly
(P< 0.01) boosted by a factor greater than two in the pres-
ence of wild-type TDG (Figure 3B). The overexpression of
TDG P65A results in an approximate 1.5-fold signiﬁcant
(P< 0.05) boost in RA-dependent reporter expression, when
compared to mock transfected cells, but the effect is
signiﬁcantly compromised in comparison to wild-type TDGoverexpression as determined by paired students t-test
(P < 0.01). In order to investigate the effect of the P65A
mutation on CBP-dependent transcription, we monitored the
expression of CBP target genes –– deﬁned as being responsive
to CBP –– upon overexpression of wild-type TDG in compar-
ison to the overexpression of TDG P65A. The expression of
CBP targets (black spots), including those among the common
subset with 5-aza-dC and RA targets (red spots), is
concomitantly regulated by the overexpression of wild-type
TDG (Figure 3C, left panel). In the case of TDG P65A over-
expression (Figure 3C, right panel), expression of 5-aza-dC
and RA-dependent CBP targets (red spots) are not affected,
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Figure 3 The TDG P65A mutation results in reduced TDG/CBP/RARa ternary complex stability
A. A representative microscale thermophoresis (MST) experiment comparing HA-tagged hTDG wt to HA-tagged hTDG P65A. Ten
successive 1:1 dilutions of immuno-puriﬁed HA-hTDG (wt or P65A mutant) in binding buffer were used for MST analyses with
YFP-CBP. The amounts of HA-fusion protein in every second dilution were monitored by Western blot using anti-HA antibody. The
protein concentration of the non-diluted HA-hTDG samples was measured by Bradford assay. B. Promoter activation assay using a
minimal Gal4 promoter driving the expression of ﬁreﬂy luciferase. The reporter construct was co-transfected with a Gal4-RARa
expression vector and, where indicated, with either wild-type or P65A mutant HA-hTDG. Luciferase activity was normalized by protein
amounts. Comparable TDG protein expression in the different conditions was veriﬁed by Western blotting. **P< 0.01 in a students t-test.
C. Scatter plot of the genes with expression signiﬁcantly (P < 0.01) regulated by CBP overexpression (X axis) upon overexpression of
TDG (Y axis) wild-type (left panel) or TDG P65A (right panel). Pearson correlation coefﬁcients for all CBP target genes were shown in
black and those for the common subset with the 5-aza-dC and RA treatments from Figure 1D are shown in red. ***P< 0.001. D. MST
experiments using increasing concentrations of puriﬁed HA-hTDG wild-type (left panel) or P65A mutant (right panel) in the presence of
non-activated (green) or RA-activated (red) puriﬁed FLAG-tagged hRARa compared to HA-hTDG wt or P65A mutant alone (control).
E. Immunoprecipitation of HA-TDG wt or P65A mutant from nuclear extracts of transiently transfected HEK293 cells in the presence or
absence of RA using anti-HA agarose. Co-immnoprecipitated proteins were monitored for RAR and CBP using the appropriate
antibodies. Mock transfected cells were used as control. Only input without RA treatment was included since addition of RA does not
affect expression of the relevant proteins (data not shown).
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pendent CBP targets (black spots) are concomitantly
regulated.
Our data indicate that the P65A mutation inﬂuences the
TDG/CBP interaction as well as RA-dependent transcription
activation via RARa and the transcription of CBP target genes
responsive to 5-aza-dC and RA. This could be potentially
explained by a ternary complex forming between all three
compounds, as it has been previously shown for TDG, RAR
and the CBP-related HAT p300 [23]. In order to answer this
question, we performed another set of MST experiments with
YFP-CBP and dilution series of immuno-puriﬁed wild-type
HA-TDG or HA-TDG P65A in the presence or absence of
non-activated (green curve) / RA-activated (red curve) puriﬁed
FLAG-RARa (Figures 3D and S2). The presence of non-
activated RARa does not lead to signiﬁcant alterations in
CBP afﬁnity for either wild-type or mutant TDG protein
(Figure 3D, green lines versus black lines), whereas the
presence of RA-activated RARa signiﬁcantly increases the
wild-type TDG afﬁnity for CBP by a factor >4 (Figure 3D,left panel, red curve), but leaves the TDG P65A/CBP binding
unchanged (Figure 3D, right panel, red line). We performed
co-immunoprecipitation experiments of wild-type HA-TDG
and HA-TDG P65A from nuclear extracts of HEK293 cells
in the presence or absence of RA to verify these ﬁndings
(Figure 3E). RAR co-immunoprecipitates with both wild-type
and mutant TDG proteins regardless of the presence of RA,
conﬁrming previous reports [7]. However, detectable amounts
of CBP only co-precipitate with wild-type TDG in the presence
of RA, strongly arguing for a ternary complex formation of
TDG, CBP and activated RARa in vivo, which is destabilized
by the P65A mutation of TDG. Remarkably, such a ternary
complex of TDG, RAR and p300 has been discovered recently,
in which TDG is required for the p300/RAR interaction and
for the recruitment of p300 to RA-regulated gene promoters
[23]. Given the signiﬁcantly different roles of p300 and CBP,
as well as the fact that CBP directly interacts with RARs in
a ligand-dependent manner in the absence of TDG, it is not
only more challenging to show such a ternary complex, but
also of signiﬁcant interest to uncover a mutual stabilization
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Figure 4 TDG P65A inﬂuences the expression of genes sensitive to de novo DNA demethylation, RA and CBP
A. Heatmap of signiﬁcant (P< 0.05) RA-responsive genes in non-transfected (Condition 1) and in CBP and wild-type hTDG
overexpressing HEK293 cells (Condition 4). The number of genes (L) that are positively (red shading) or negatively (blue shading)
regulated is shown together with the average over three independent biological replicate signals of each experimental condition and the
corresponding control condition (S). Expression changes of these genes upon 5-aza-dC treatment (Condition 2), CBP overexpression
(Condition 3) as well as RA treatment during simultaneous overexpression CBP and hTDG P65A (Condition 6) are displayed as heat
maps. Cells overexpressing TDG wt (Condition 5) or P65A mutant (Condition 7) alone and subjected to RA treatment were used as
control. Post-hoc P values are indicated as color code (P). B. Scatter plot of the genes shown in panel A. RA-mediated differential
expression was compared between cells overexpressing CBP and hTDG wt (X axis) and cells overexpressing CBP and hTDG P65A mutant
(Y axis). Genes with expression signiﬁcantly (P< 0.05) impacted in the hTDG P65A condition are highlighted in red. Pearson correlation
coefﬁcients for both non-signiﬁcant (black) and signiﬁcant subsets are indicated. C. Relative difference in RA-responsiveness of cells
overexpressing CBP and hTDG P65A mutant in relative to cells overexpressing CBP and hTDG wt. The RA-responsiveness was
normalized to the CBP/hTDG wt condition. Genes whose expression is signiﬁcantly (P< 0.05) affected by RA treatment during CBP and
hTDG P65A expression are highlighted in red, whereas genes with RA-dependent expression signiﬁcantly (P < 0.05) affected during CBP
and wild-type hTDG expression are highlighted in blue.
14 Genomics Proteomics Bioinformatics 12 (2014) 8–18within the complex. The fact that the P65A mutation prevents
ternary complex formation with CBP and activated RARa
in vitro makes TDG P65A a useful tool to functionally charac-
terize the ternary TDG/CBP/RARa complex.
Disruption of TDG/CBP/RARa ternary complex deregulates
RA-dependent gene expression
In order to assess the role of the complex of TDG and CBP
with activated RARa in gene expression regulation, we
co-transfected HEK293 cells with wild-type TDG and CBP
and compared the RA-responsive transcriptome proﬁle with
cells co-expressing TDG P65A and CBP. Thereby, we focusedon genes consistently co-regulated upon RA treatment in the
wild-type TDG/CBP condition and in non-treated cells, in
order to avoid side-effects caused by TDG/CBP overexpres-
sion. In both conditions, a total of 152 genes were signiﬁcantly
(P< 0.05) differentially expressed upon RA treatment, among
which, expression of 144 and 8 genes was up-regulated and
down-regulated, respectively (Figure 4A, Conditions 1 and
4). Notably, these genes showed similar expression changes
upon 5-aza-dC treatment and CBP overexpression (Figure 4A,
Conditions 2 and 3). Assessing their differential expression
upon RA treatment in the TDG P65A/CBP condition reveals
a global deregulation of gene expression (Figure 4A, Condition
6). It is worth noting that the vast majority of these genes do
Le´ger H et al / TDG:CBP:RAR in Transcription and Epigenomics 15not respond to RA in a signiﬁcant manner when either
wild-type TDG or TDG P65A is overexpressed alone
(Figure 4A, Conditions 5 and 7), arguing for CBP and TDG
being in conjunction important for the RA responsiveness of
those genes. A comparison of the log2-fold changes of the
RA-dependent genes in the wild-type TDG/CBP condition
(X axis) with those in the TDG P65A/CBP condition (Y axis)
shows that expression of the majority of genes is not signiﬁ-
cantly regulated upon RA treatment in TDG P65A/CBP
expressing cells (Figure 4B, black spots). Expression of only
30 genes (20%) is signiﬁcantly (P< 0.05) regulated in the
TDG P65A/CBP condition as well, of which notably expres-
sion of 19 genes is regulated in the opposite manner, when
compared to the wild-type TDG/CBP condition (Figure 4B,
red spots). We calculated the change in RA responsiveness
caused by the introduction of TDG P65A as the difference
of the RA-induced change of gene expression between TDG
P65A/CBP and wild-type TDG/CBP expressing cells, which
is normalized to the wild-type TDG/CBP condition
(Figure 4C). While expression of only 6 genes (4%) shows a
stronger RA responsiveness in the presence of TDG P65A/
CBP (Figure 4C, red), the RA responsiveness of the remaining
146 genes is severely reduced when compared to wild-type
TDG/CBP (Figure 4C, blue). Notably, we observe a set of
genes, whose responsiveness to RA is inversed by the introduc-
tion of TDG P65A (Figure 4C, change in RA responsiveness
lower than 1).
Conclusion
Our ﬁndings point at the existence of a transcriptionally active
ternary complex composed of TDG, CBP and activated
RARa. The single interactions between each two of the three
compounds add up to a high afﬁnity complex in vitro, which
may activate RA-dependent gene expression in vivo in a similar
way as it has been suggested for RARa, TDG and p300 [23]
(Figure 5). However, functional studies of ternary complexes
composed of independent catalytically active components con-
stitute a major challenge in vivo. Here, we have functionallyCBP
RARα TDG
CBP
TDGRARα
RA
RA
CBP
RARα
CBP
RARα
RA
RA
P65A P65A
RA-dependent 
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Figure 5 Model of ternary CBP:TDG:RAR complex action
The interaction of CBP with RA-activated RARa cooperates with
the interactions of TDG with CBP and RARa in order to stabilize
a ternary complex composed of all three molecules, which affects
the expression of RA-dependent genes (top). The P65A mutant of
TDG is still able to interact with RARa, but fails to bind CBP,
resulting in the inability to form a stable functional ternary
complex (bottom).characterized a TDG point mutation, P65A, which is capable
of substantially affecting ternary complex stability and
transcription regulatory activity, and thus may serve as a
powerful tool for future in vivo studies in order to address
the biological role of the TDG/CBP/RARa complex. The
recent ﬁndings of a point mutation, R66G, in the very same
region of TDG in patients with colorectal cancer further
substantiates the functional importance of this region and thus
may provide a link between the ternary TDG/CBP/RARa
complex and the development of this pathology [32,35].
Materials and methods
Plasmids
The TDG P65A mutant was produced by site-directed muta-
genesis, exchanging the codon for proline 65 (CCC) into an
alanine codon (GCC). TDG wt and the mutant TDG P65A
were cloned into the BglII/SacI cloning sites of pSG5 plasmid
(Agilent) to obtain HA-fusion proteins. CBP was cloned into
the BglII cloning site of pEYFP plasmid (Clontech). Flag-
RARa fusion proteins have been described previously [7].
For bacterial expression, full-length TDG (residues 1–410),
its isolated N-terminal domain (residues 1–111) and the corre-
sponding P65A mutants were cloned into the BamHI/EcoRI
cloning sites of pGEX-6P-1 plasmid (GE Healthcare).
Cell culture
COS-7 and HEK293 cells were cultured at 37 C in 5% CO2 in
DMEM medium supplemented with 10% fetal calf serum
(FCS) and with 1% penicillin/streptomycin. Transfections
were performed using FugeneHD (Roche) according to the
manufacturer’s instructions. Cells were treated with a ﬁnal
concentration of 5 · 107 M atRA dissolved in ethanol or
5-aza-20-deoxycytidine (5-aza-dC) dissolved in DMSO for
24 h. Cells were grown to 4–6 · 105 cells/ml prior to harvesting
for extract preparation.
Extract preparations
Cells were pelleted by centrifugation at 5000g for 5 min
at room temperature. The cell pellet was resuspended in cold
phosphate buffered saline (PBS) and collected by centrifuga-
tion at 5000g for 5 min at room temperature. All subsequent
steps were performed at 4 C. The cells were suspended in
three volumes of lysis buffer (50 mM Tris/HCl pH 7.4,
150 mM NaCl, 1 mM EDTA, 1% Triton X-100) and homog-
enized for 30 min at 4 C, mixing the sample head-over-tail.
Cellular debris was removed by high speed centrifugation
(16,000g for 10 min at 4 C). The supernatant was subse-
quently dialyzed against buffer D (0.1 M KCl, 20 mM HEPES
pH 7.9, 0.2 mM EDTA, 20% glycerol) and directly used for
immunoprecipitation experiments. Nuclear extracts were
prepared as described previously [36].
Immunoprecipitations
20 ll of anti-FLAG agarose or anti-HA agarose (Sigma
Aldrich) was washed 3 times with 500 ll of IP buffer
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and 20% glycerol, Sigma Aldrich) supplemented with 0.1%
Tween 20. A 50% mixture of whole cell extracts or nuclear
extracts and IP buffer was added and incubated for 1 h to
overnight mixing head-over-tail at 4 C. Empty FLAG and
HA expression vectors were transfected to generate the
appropriate control extracts. The bead slurry was washed 3
times using IP buffer, before the puriﬁed protein was eluted
by the addition of IP elution buffer (Sigma Aldrich) and
subsequently dialyzed against buffer D. In the case of
co-immunoprecipitation analyses, the proteins were eluted by
incubating with Laemmli sample buffer at 95 C prior to
Western blot analyses. Protein concentrations were determined
using the Bradford method (Bio-Rad).
Western blot analyses
A total of 20–50 lg of soluble protein or eluates from
immunopuriﬁcations were separated using SDS–polyacrylamide
gels, transferred to a nitrocellulose membrane (Bio-Rad) and
incubated with blocking buffer (1· PBS with 0.1% Tween 20
and 5% skimmed milk) for 1 h at room temperature. Blocked
membranes were washed twice with PBS-T (1· PBS with 0.1%
Tween 20) for 5 min before incubation with a 1:2500 dilution
of the primary antibody for 45 min at room temperature in
PBS-T. Antibodies used were mouse monoclonal anti-HA
(clone12CA5) antibody (Roche), mouse monoclonal anti-
FLAG antibody (Sigma Aldrich), rabbit polyclonal anti-CBP
antibody (Santa Cruz) and mouse polyclonal anti-RAR
antibody (Millipore). Membranes were washed three times
with PBS-T at room temperature for 5 min and subsequently
incubated with a horseradish peroxidase–conjugated anti-
mouse or anti-rabbit secondary antibody (Sigma Aldrich) at
a dilution of 1:5000 in blocking buffer for 45 min at room
temperature. After three washing steps of 5 min each with
PBS-T at room temperature, detection of the signals was
carried out using the ECL Plus Western Blotting Substrate
(Pierce).
Glycosylase activity assays
Oligonucleotide primers used to generate 25-mer dsDNA con-
taining either a central G:T or G:U mismatch basepair were as
follows: 50-GAT AGG TTC CAC G(G)G TAC TCG AAG
C-30 as the forward primer and 50-GCT TCG AGT AC(T/U)
CGT GGA ACC TAT G-30 as the reverse primer (the nucleo-
tides involved in the G:T(U) mismatches are written in brack-
ets). DNA nicking assays were performed as described
previously [37] on this 25-mer dsDNA and a 25-mer dsRNA
containing a central canonical G:C pair as a control. Brieﬂy,
oligonucleotides corresponding to the complementary strand
were labeled on the primary amine modiﬁed 30-end with the
AlexaFluor 488 dye (Invitrogen) and oligonucleotide anneal-
ing was performed by heating 1 mM solutions for 5 min at
100 C and cooling down the mixtures slowly to room temper-
ature. TDG proteins were incubated at 0.5 lM ﬁnal concentra-
tions with dsDNA at 5 lM in 80 ll nicking buffer (25 mM
HEPES/KOH pH 7.8, 1 mM EDTA, 1 mM DTT) at 37 C.
20 ll aliquots were withdrawn at different incubation time
points. DNA was precipitated in 70% ethanol solution con-
taining 300 mM NaCl and then incubated with 0.01 N NaOHfor 30 min at 50 C. Oligonucleotides were separated by dena-
turing polyacrylamide gel electrophoresis and quantiﬁed using
a GeneGenius bioimaging system (SynGene, Ozyme). Three
independent replicates of glycosylase reactions were performed
for each time point of the kinetic studies. The enzymatic
turnover was normalized by the amount of protein used, as
detected by the Bradford assay.
Microscale thermophoresis
Microscale thermophoresis (MST) technique capitalizes from
the fact that molecules move in a temperature gradient from
hot to cold (thermophoresis). This movement is impacted by
complex formation, since molecules in a complex show an
altered velocity. MST technique is used to measure the
thermophoresis of a ﬂuoresently labeled molecule (here
YFP-CBP) subject to increasing concentrations of a binding
partner (here immuno-puriﬁed TDG or TDG P65A). To
obtain a series of successively decreasing TDG concentrations,
immuno-puriﬁed HA-TDG samples (or HA-TDG P65A) were
diluted up to 14 times with buffer D (1:1, 1:4, 1:8, etc.). The
same amount of YFP-CBP containing cellular extract was
added to each dilution in the presence or absence of
immuno-puriﬁed FLAG-tagged RARa either in the presence
or in the absence of RA. The reaction conditions were set to
20 mM MgCl2. MST experiments were conducted using a
Monolith NT.115 (Nanotemper Technologies) as described
previously [33,34] (laser-power 20%, laser-on time 60s,
LED-power 30%).
Luciferase reporter assays
Cells were transfected with a mixture of plasmids containing
1 lg 17-mer b-globin-Luc, 50 ng pRL SV40, 50 ng Gal4-
hRARa 1.5 lg pSG5-hTDGwt or pSG5-hTDG P65A and
1.5 lg pSG5 DNA in 50 ll total volume to which 12 ll of
Exgen 500 (Fermentas) was added according to the manufac-
turer’s instructions. After 6 h, the transfection reaction was
stopped by adding 180 ll of DMEM to each well. Then cells
were treated with atRA at 5 · 107 M for 24 h. After incuba-
tion, cells were washed with PBS and lysed with 20 ll of
Passive Lysis Buffer (Promega) at room temperature for
15 min before reading. Luciferase activity was subsequently
measured using GloMax-96 Microplate Luminometer
(Promega) according to the manufacturer’s instructions and
normalized by protein amounts.
NMR studies
Full-length TDG wild-type and the mutant TDG P65A and
their isolated N terminal domains for NMR studies were
overexpressed as GST fusion proteins in Escherichia coli
BL21 (DE3) strain. Protein expression and puriﬁcation were
performed as described previously [37,38]. NMR experiments
were performed at 293 K on a Bruker DMX 600 MHz
spectrometer (Bruker, Karlsruhe, Germany) equipped with a
cryogenic triple resonance probe head. All 1H spectra were
calibrated with 1 mM sodium 3-trimethylsilyl-d(3,30,2,20)-
propionate as a reference. All 1H–15N HSQC spectra were
recorded in an aqueous buffer composed of 100 mM NaiPO4
pH 6.6, 1 mM EDTA, 1 mM DTT and 5% D2O.
1H–15N
Le´ger H et al / TDG:CBP:RAR in Transcription and Epigenomics 17HSQC spectra were recorded on 100 lM samples of
15N-labeled proteins with 128 scans per increment and 128
dummy scans, 128 points in the nitrogen dimension and 1024
points in the proton dimension.
Total RNA preparation
Total RNA from transfected or non-transfected cells was pre-
pared using the RNeasy Midi Kit (Qiagen) as recommended by
the manufacturer.
Transcriptome analyses
Microarray analyses, RNA ampliﬁcation, labeling, hybridiza-
tion and detection were performed following the protocols sup-
plied by Applied Biosystems using the corresponding kits
(AppliedBiosystems). Themicroarray datawere extracted using
the Bioconductor limma package [39] and median normalized.
Data quality was determined using a QC procedure [40]. Data
were normalized using NeONORM with k= 0.02 [41–43].
Subtraction proﬁling was performed as described previously
[44,45] using the CDS test [46]. Differentially expressed genes
were classiﬁed using Ingenuity Pathway Analysis software to
detect network- and pathway-enrichments. Transcriptome data
were deposited in the public database MACE (http://mace.
ihes.fr) using Accession Nos: 3167467256 (5-aza-dC treatment
HEK293 cells), 2426124024 (RA treatment HEK293 cells),
2147989240 (CBP overexpression HEK293 cells), 2267526904
(RA treatment of TDG(TDGP65A)/CBP expressing HEK293
cells), 2586598264 (5-aza-dC treatment COS-7 cells),
2283559800 (RA treatment COS-7 cells), 2740738936 (CBP
overexpression COS-7 cells), 2763807608 (RA treatment of
TDG/CBP expressing HEK293 cells), 2549898104 (RA
treatment of TDGP65A/CBP expressing HEK293 cells),
2901761912 (wild-type TDG overexpression in HEK293 cells)
and 2890751864 (TDG P65A overexpression in HEK293 cells).Authors’ contributions
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